Cytokinetics (CYTK) has released an update to notify the public and investors about its officers.
Ching W. Jaw, Senior Vice President & Chief Financial Officer of Cytokinetics, Incorporated, announced his resignation effective February 23, 2024, due to a personal health condition. His departure is amicable and mutually agreed upon with the Company.
For further insights into CYTK corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
